Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. The sudden price rise can be attributed to growing investor optimism related to increased sales of the company's portfolio of products that are marketed targeting oncology, immunology, neuroscience and infectious disease. This company is expected to post quarterly loss o ...

Group 1 - IDEX Corporation (IEX) shares increased by 7.3% to close at $173.80, following a period of 12.4% loss over the past four weeks, indicating notable trading volume [1][2] - The rally is attributed to optimism regarding IDEX's strong momentum in the intelligent water business and the Trump administration's temporary halt on reciprocal tariffs for most countries [2] - IDEX is expected to report quarterly earnings of $1.64 per share, reflecting a year-over-year decline of 12.8%, while revenues are projected to be $811.61 million, an increase of 1.4% from the previous year [3] Group 2 - The consensus EPS estimate for IDEX has remained unchanged over the last 30 days, suggesting that stock price movements may not sustain without trends in earnings estimate revisions [5] - IDEX holds a Zacks Rank of 3 (Hold), indicating a neutral outlook, while another stock in the same industry, DNOW, has a Zacks Rank of 1 (Strong Buy) [5][6] - DNOW's consensus EPS estimate is $0.19, representing a decline of 9.5% from the previous year, and the stock finished the last trading session 10.4% higher at $15.66 [6]